NREP
NEW REPRESENTATIVE AT IB RECEIVED
04/10/2025
Back to search
Official data from USPTO
NEXTPHARMA
Did you know this trademark is already registered in United States?
Before investing in name, identity, and promotion, validate collision risk and registration strategy to avoid wasting time and budget.
Active USPTO registrationType: CombinedOffice: US
Risk and opportunity diagnosis
Executive reading for naming, filing, and monitoring decisions.
USPTO status
Active USPTO registration
Case type
Application and registration
Recorded events
72
Latest update
04/11/2025
Classification
Registered
Trademark type
Combined
Nice classes
5, 39, 42
Filing date
05/23/2008
Registration date
12/14/2010
Expiration date
-
Recommended action
Perform a full collision analysis and validate classes before any filing or trademark investment.
Next step
These are the details of the registration process. Even so, constant monitoring is what ensures peace of mind that your main asset remains protected.
Complete case details
Structured fields from the responsible authority and the official record.
Status date
01/25/2021
Last transaction
04/11/2025
Responsible office
United States Patent and Trademark Office
Status code
706
Official register
Principal Register
Drawing code
3
Owner type
03
Owner location
GB
Examiner
MORRIS, KRISTINA
Law office
M70
Current location
GENERIC WEB UPDATE
Holders and representatives
Holders
NextPharma Technologies Holding Limited
NextPharma Technologies Holding Limited
NextPharma GmbH
Representatives
Stacey R. Halpern Knobbe Martens Olson & Bear
Technical classification
Nice Classes
Class 5Class 39Class 42
Vienna Codes
No Vienna codes available.
Goods and services
Class 5
Sanitary preparations for medical purposes; dietetic substances adapted for medical usedietary food supplementsfood for babies; medical plastersmaterials for medical dressings; material for stopping teethdental waxdisinfectants for sanitary purposes; preparations for destroying vermin; pesticidesfungicidesherbicides
Class 39
Transportation of pharmaceutical preparations by roadrailair and sea transportation; packaging for transportation and storage of goodspharmaceutical preparations
Class 42
Development of pharmaceutical products for others
Publications
History of USPTO decisions and trademark events.
72 publications found
ADCH
CHANGE OF NAME/ADDRESS REC'D FROM IB
04/22/2022
INNA
INVALIDATION REVIEWED - NO ACTION REQUIRED BY OFFICE
10/08/2021
INPR
PARTIAL INVALIDATION OF REG EXT PROTECTION CREATED
09/25/2021
NREP
NEW REPRESENTATIVE AT IB RECEIVED
05/09/2021
NA71
NOTICE OF ACCEPTANCE OF SEC. 71 - E-MAILED
01/25/2021
71AG
REGISTERED-SEC.71 ACCEPTED
01/25/2021
APRE
CASE ASSIGNED TO POST REGISTRATION PARALEGAL
01/20/2021
ES71
TEAS SECTION 71 RECEIVED
11/06/2020
REM4
COURTESY REMINDER - SEC. 71 (10-YR) E-MAILED
12/14/2019
RNWL
INTERNATIONAL REGISTRATION RENEWED
06/07/2018
ADCH
CHANGE OF NAME/ADDRESS REC'D FROM IB
04/05/2018
NREP
NEW REPRESENTATIVE AT IB RECEIVED
03/30/2018
INNP
PARTIAL INVALIDATION PROCESSED BY THE IB
03/16/2018
XXSS
GENERIC MADRID TRANSACTION SENT TO IB
01/25/2018
XXCR
GENERIC MADRID TRANSACTION CREATED
01/25/2018
INPR
PARTIAL INVALIDATION OF REG EXT PROTECTION CREATED
01/12/2018
NA71
NOTICE OF ACCEPTANCE OF SEC. 71 - E-MAILED
05/12/2017
71.P
REGISTERED - PARTIAL SEC 71 ACCEPTED
05/12/2017
APRE
CASE ASSIGNED TO POST REGISTRATION PARALEGAL
05/12/2017
ES71
TEAS SECTION 71 RECEIVED
12/14/2016
REM3
COURTESY REMINDER - SEC. 71 (6-YR) E-MAILED
12/14/2015
TMBN
TTAB RELEASE CASE TO TRADEMARKS
08/21/2013
CANT
CANCELLATION TERMINATED NO. 999999
08/21/2013
CAND
CANCELLATION DENIED NO. 999999
08/21/2013
PETC
CANCELLATION INSTITUTED NO. 999999
05/13/2013
FINO
FINAL DECISION TRANSACTION PROCESSED BY IB
02/17/2013
TCCA
TEAS CHANGE OF CORRESPONDENCE RECEIVED
06/18/2011
FICS
FINAL DISPOSITION NOTICE SENT TO IB
04/13/2011
FIMP
FINAL DISPOSITION PROCESSED
04/13/2011
FICR
FINAL DISPOSITION NOTICE CREATED, TO BE SENT TO IB
03/14/2011
R.PR
REGISTERED-PRINCIPAL REGISTER
12/14/2010
NPUB
OFFICIAL GAZETTE PUBLICATION CONFIRMATION E-MAILED
09/28/2010
PUBO
PUBLISHED FOR OPPOSITION
09/28/2010
PREV
LAW OFFICE PUBLICATION REVIEW COMPLETED
08/25/2010
CNSA
APPROVED FOR PUB - PRINCIPAL REGISTER
08/18/2010
TEME
TEAS/EMAIL CORRESPONDENCE ENTERED
08/11/2010
CRFA
CORRESPONDENCE RECEIVED IN LAW OFFICE
08/10/2010
ERFR
TEAS REQUEST FOR RECONSIDERATION RECEIVED
08/10/2010
OPNX
NOTIFICATION OF POSSIBLE OPPOSITION - PROCESSED BY IB
03/26/2010
GNS1
NOTIFICATION OF SUBSEQUENT FINAL EMAILED
03/16/2010
GNSF
SUBSEQUENT FINAL EMAILED
03/16/2010
CFRC
SUBSEQUENT FINAL REFUSAL WRITTEN
03/16/2010
OPNS
NOTIFICATION OF POSSIBLE OPPOSITION SENT TO IB
03/11/2010
OPNR
NOTIFICATION OF POSSIBLE OPPOSITION CREATED, TO BE SENT TO IB
03/11/2010
TCCA
TEAS CHANGE OF CORRESPONDENCE RECEIVED
02/23/2010
TEME
TEAS/EMAIL CORRESPONDENCE ENTERED
02/23/2010
CRFA
CORRESPONDENCE RECEIVED IN LAW OFFICE
02/23/2010
TROA
TEAS RESPONSE TO OFFICE ACTION RECEIVED
02/23/2010
CNRT
NON-FINAL ACTION MAILED
08/25/2009
CNRT
NON-FINAL ACTION WRITTEN
08/24/2009
TEME
TEAS/EMAIL CORRESPONDENCE ENTERED
08/12/2009
CRFA
CORRESPONDENCE RECEIVED IN LAW OFFICE
08/12/2009
ERFR
TEAS REQUEST FOR RECONSIDERATION RECEIVED
08/06/2009
EXPI
EX PARTE APPEAL-INSTITUTED
08/06/2009
JURT
JURISDICTION RESTORED TO EXAMINING ATTORNEY
08/06/2009
EXAF
EXPARTE APPEAL RECEIVED AT TTAB
08/06/2009
CHLD
CHANGE OF OWNER RECEIVED FROM IB
06/11/2009
CNFR
FINAL REFUSAL MAILED
02/06/2009
CNFR
FINAL REFUSAL WRITTEN
02/05/2009
ACEC
AMENDMENT FROM APPLICANT ENTERED
01/15/2009
CRFA
CORRESPONDENCE RECEIVED IN LAW OFFICE
01/15/2009
ALIE
ASSIGNED TO LIE
01/15/2009
PAPER RECEIVED
01/12/2009
RFNT
REFUSAL PROCESSED BY IB
10/31/2008
RFCS
NON-FINAL ACTION MAILED - REFUSAL SENT TO IB
10/14/2008
RFRR
REFUSAL PROCESSED BY MPU
10/14/2008
RFCR
NON-FINAL ACTION (IB REFUSAL) PREPARED FOR REVIEW
10/12/2008
CNRT
NON-FINAL ACTION WRITTEN
10/11/2008
DOCK
ASSIGNED TO EXAMINER
10/10/2008
NWAP
NEW APPLICATION ENTERED
10/10/2008
REPR
SN ASSIGNED FOR SECT 66A APPL FROM IB
10/09/2008
Continuous trademark protection
Get notified about every new filing that threatens NEXTPHARMA or your mark.
Professional 24-month watch service: we monitor USPTO for you and alert you in time to oppose — before conflicts become losses.